Publications

Challenges for decision-makers when assessing within-class comparative effectiveness: the case of anticoagulation therapy for atrial fibrillation. 2022

Cost impact analysis of novel host-response diagnostic for patients with community-acquired pneumonia in the emergency department. 2022

Beyond Ten-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease. 2022

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations. 2022

Developing a Framework for the Health Technology Assessment of Histology-independent Precision Oncology Therapies. 2021

Reimbursement for genetic variant reinterpretation: five questions payers should ask. 2021

Count the cost of disability caused by COVID-19. 2021

Estimating (quality-adjusted) life-year losses associated with deaths: With application to COVID-19. 2021

Mendelian randomization: estimation of inpatient hospital costs attributable to obesity. 2021

An Attribution of Value Framework for Combination Therapies: Report by the Value Attribution Working Group. 2021

Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States. 2021

Genetic Variant Reinterpretation: Economic and Population Health Management Challenges. 2021

A Cost-Offset Analysis of the Roxadustat Incident Dialysis-Dependent Global Phase 3 Program: A US Healthcare Perspective. 2021

A Cost-Offset Analysis of the Roxadustat Incident Dialysis-Dependent Global Phase 3 Program: A Canadian Healthcare Perspective. 2021

Cost Impact Model of a Novel Multi-mRNA Host Response Assay for Diagnosis and Risk Assessment of Acute Respiratory Tract Infections and Sepsis in the Emergency Department. 2020

Covariate-adjusted Analysis of the Phase 3 REFLECT Study of Lenvatinib Versus Sorafenib in the Treatment of Unresectable Hepatocellular Carcinoma. 2020

Application of a simple point-of-care test to reduce UK healthcare costs and adverse events in outpatient acute respiratory infections. 2020

Real-world evidence on clinical outcomes in immune thrombocytopenia treated with thrombopoietin receptor agonists. 2020

Economic evaluation of cardiac magnetic resonance with Fast-SENC in the diagnosis and management of early heart failure. 2019

Cost-impact of cardiac magnetic resonance imaging with Fast-SENC compared to SPECT in the diagnosis of coronary artery disease in the U.S. 2019

Economic evaluation of passive monitoring technology for seniors. 2019

3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT. 2019

Comparison of health state utility estimates from instrument-based and vignette-based methods: a case study in kidney disease. 2019

Economic evaluation of passive monitoring technology for seniors. 2019

A quality of life mapping function developed from a grass pollen sublingual immunotherapy trial to a tree pollen sublingual immunotherapy trial. 2019

SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer. 2018

Effect of theophylline as adjunct to inhaled corticosteroids on exacerbations in patients with COPD: a randomized clinical trial. 2018

Behavioural activation versus guided self-help for depression in adults with learning disabilities: the BeatIt RCT. 2018

Comparison between high-sensitivity cardiac troponin T and cardiac troponin I in a large general population cohort. 2018

Long-term weight loss following a randomised controlled trial of a weight management programme for men delivered through professional football clubs: the Football Fans in Training follow-up study. 2018

A decision-analytic model to assess the cost-effectiveness of etelcalcetide vs. cinacalcet. 2018

Enhancing the value of the ASCO value framework. 2018

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial. 2018

Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Angina (CorMicA) stratified medicine clinical trial. 2018

A decision framework for treating chronic immune thrombocytopenia with thrombopoietin receptor agonists. 2018

High-Sensitivity Troponin T and Incident Heart Failure in Older Men: British Regional Heart Study. 2018

Highest risk-highest benefit’ strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies. 2018

Long-term weight loss trajectories following participation in a randomised controlled trial of a weight management programme for men delivered through professional football clubs: A longitudinal cohort study and economic evaluation. 2018

The feasibility of a randomised-controlled trial to compare the cost-effectiveness of palliative cardiology or usual care in people with advanced heart failure: two exploratory prospective cohorts. 2018

Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction. 2018

Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective. 2018

EQ-5D-5L: Smaller steps but a major step change? 2018.

Estimating the Long-Term Outcomes Associated With ImmunoOncology Therapies: Challenges and Approaches for Overall Survival Extrapolations. 2018

Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a Chinese hospital system perspective. 2017

A Methodological Approach for Measuring the Impact of HTA. 2017

Assessing the impact of state “opt-out” policy on access to and costs of surgeries and other procedures requiring anesthesia services. 2017

Comparison of behavioural activation with guided self-help for treatment of depression in adults with intellectual disabilities: a randomised controlled trial 2017

Systematic scoping review of patients’ perceived needs of health services for osteoporosis 2017

Evaluation of Health in Pregnancy grants in Scotland: a natural experiment using routine data 2017

Models of Care for musculoskeletal pain conditions: driving change to improve outcomes 2017

Protocol for an economic evaluation of the randomised controlled trial of culprit lesion only PCI versus immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: CULPRIT-SHOCK trial. 2017

End user and implementer experiences of mHealth technologies for noncommunicable chronic disease management in young adults: a qualitative systematic review protocol. 2017

Health-related quality-of-life implications of cardiovascular events in individuals with type 2 diabetes mellitus: A subanalysis from the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus (SAVOR)-TIMI 53 trial 2017

An analysis of procedures that affect response variability 2017

PATHway I: design and rationale for the investigation of the feasibility, clinical effectiveness and cost-effectiveness of a technology-enabled cardiac rehabilitation platform 2017

Development of a Conceptual Model of Disease Progression for Use in Economic Modeling of Chronic Obstructive Pulmonary Disease 2017

Statistical Modeling of Disease Progression for Chronic Obstructive Pulmonary Disease Using Data from the ECLIPSE Study 2017

Cost-effectiveness Analysis in R Using a Multi-state Modeling Survival Analysis Framework: A Tutorial. 2017

Development of the Galaxy Chronic Obstructive Pulmonary Disease (COPD) Model Using Data from ECLIPSE: Internal Validation of a Linked-Equations Cohort Model 2017

Outcomes of Surgeries Performed in Physician Offices Compared With Ambulatory Surgery Centers and Hospital Outpatient Departments in Florida. 2017

Detection in blood of autoantibodies to tumour antigens as a case-finding method in lung cancer using the EarlyCDT®-Lung Test (ECLS): study protocol for a randomized controlled trial. 2017

Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a Chinese hospital system perspective. 2017

Health impact assessment of the UK soft drinks industry levy: a comparative risk assessment modelling study 2017

Cost impact of unexpected disposition after orthopedic ambulatory surgery associated with category of anesthesia provider. 2016

The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought 2016

A View from the Bridge: Health Economic Evaluation – A Value-Based Framework? 2016

Analyzing Health-Related Quality of Life in the EVOLVE Trial: The Joint Impact of Treatment and Clinical Events 2016

The SCottish Alcoholic Liver disease Evaluation: A Population-Level Matched Cohort Study of Hospital-Based Costs, 1991-2011. 2016

Close Contact Casting vs Surgery for Initial Treatment of Unstable Ankle Fractures in Older Adults: A Randomized Clinical Trial 2016

Patient Heterogeneity in Health Economic Decision Models for Chronic Obstructive Pulmonary Disease: Are Current Models Suitable to Evaluate Personalized Medicine? 2016

Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report 2016

Unrelated Future Costs and Unrelated Future Benefits: Reflections on NICE Guide to the Methods of Technology Appraisal 2016

Determination of the most appropriate method for extrapolating overall survival data from a placebo-controlled clinical trial of lenvatinib for progressive, radioiodine-refractory differentiated thyroid cancer 2016

A cardiovascular disease policy model: part 2-preparing for economic evaluation and to assess health inequalities 2016

Editorial. 2016

Spacing Pregnancies Appropriately: Long-Acting Reversible Contraception in the Immediate Postpartum Period. 2016

In-office magnetic resonance imaging (MRI) equipment ownership and MRI volume among Medicare patients in orthopedic practices. 2015

Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failure 2016

Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective. 2015

The Economics Of Critical Care Diagnostics: The Case Of Procalcitonin-Guided Care In Treatment Of Acute Respiratory Infection In The U.S. 2015

The Economics Of Critical Care Diagnostics: The Case Of Procalcitonin-Guided Care In Treatment Of Acute Respiratory Infection In The U.S. 2015

Operationalising the capability approach as an outcome measure in public health: The development of the OCAP-18 2015

Decision analytic cost-effectiveness model to compare prostate cryotherapy to androgen deprivation therapy for treatment of radiation recurrent prostate cancer. 2015

Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective. 2015

Hospital Expenditure at the End-of-Life: What Are the Impacts of Health Status and Health Risks? 2015

A cardiovascular disease policy model that predicts life expectancy taking into account socioeconomic deprivation. 2015

Temporal trends and risk factors for readmission for infections, gastrointestinal and immobility complications after an incident hospitalisation for stroke in Scotland between 1997 and 2005. 2015

Can Improved Treatment of Allergic Rhinitis Improve Workplace Productivity? The Role of Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate (Dymista). 2014

Can Improved Treatment of Allergic Rhinitis Improve Workplace Productivity? The Role of Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate (Dymista). 2014

The progressivity of health-care financing in Kenya. 2014

Methods for Specifying the Target Difference in a Randomised Controlled Trial: The Difference ELicitation in TriAls (DELTA) Systematic Review. 2014

Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review. 2014

Projecting long-term graft and patient survival after transplantation. 2014

Questionnaire to assess relevance and credibility of modeling studies for informing health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report. 2014

Statistical Issues in Economic Evaluations. 2014

Population ageing and healthcare expenditure projections: new evidence from a time to death approach. 2013

A patient-centred approach to estimate total annual healthcare cost by body mass index in the UK Counterweight programme. 2013

How effective is the Forestry Commission Scotland’s woodland improvement programme–‘Woods In and Around Towns’ (WIAT)–at improving psychological well-being in deprived urban communities? A quasi-experimental study. 2013

Time trends in 30 day case-fatality following hospitalisation for asthma in adults in Scotland: a retrospective cohort study from 1981 to 2009. 2013

Prognosis Research Strategy (PROGRESS) 2: prognostic factor research. 2013

Organizational boundaries of medical practice: the case of physician ownership of ancillary services. 2012

Tobacco litter costs and public policy: a framework and methodology for considering the use of fees to offset abatement costs. 2011

Effects of health savings account-eligible plans on utilization and expenditures. 2011

Converting to critical access status: how does it affect rural hospitals’ financial performance? 2009

Factors associated with Iowa rural hospitals’ decision to convert to critical access hospital status. 2009

Cost effectiveness of a point-of-care test for adenoviral conjunctivitis. 2008

Cost effectiveness of a point-of-care test for adenoviral conjunctivitis. 2008

The economics of specialty hospitals. 2008

Effects of specialty hospitals on the financial performance of general hospitals, 1997-2004. 2007

Effect of critical access hospital conversion on patient safety. 2007

Clinical practice guidelines and organizational adaptation: a framework for analyzing economic effects. 2006

Implementation of hospital computerized physician order entry systems in a rural state: feasibility and financial impact. 2005

What would be the effect of referral to high-volume hospitals in a largely rural state? 2004A quality of life mapping function developed from a grass pollen sublingual immunotherapy trial to a tree pollen sublingual immunotherapy trial

Count the cost of disability caused by COVID-19. 2021

Estimating (quality-adjusted) life-year losses associated with deaths: With application to COVID-19. 2021

Online Simulation Model to Estimate the Total Costs of Tobacco Product Waste in Large U.S. Cities. 2020

Online Simulation Model to Estimate the Total Costs of Tobacco Product Waste in Large U.S. Cities. 2020

Enhancing Health Through Access to Nature: How Effective are Interventions in Woodlands in Deprived Urban Communities? A Quasi-experimental Study in Scotland, UK. 2019

The Economics of Reasonable Value and the Valuation of Medical Losses. 2019

What is the Reasonable Value of Future Medical Care? 2019

Evaluation of Health in Pregnancy grants in Scotland: a natural experiment using routine data. 2017

Assessing the impact of state “opt-out” policy on access to and costs of surgeries and other procedures requiring anesthesia services. 2017

Outcomes of Surgeries Performed in Physician Offices Compared With Ambulatory Surgery Centers and Hospital Outpatient Departments in Florida. 2017

Are financial incentives cost-effective to support smoking cessation during pregnancy? 2016

Cost impact of unexpected disposition after orthopedic ambulatory surgery associated with category of anesthesia provider. 2016

In-office magnetic resonance imaging (MRI) equipment ownership and MRI volume among medicare patients in orthopedic practices. 2015

The progressivity of health-care financing in Kenya. 2014

Organizational boundaries of medical practice: the case of physician ownership of ancillary services. 2012

Tobacco litter costs and public policy: a framework and methodology for considering the use of fees to offset abatement costs. 2011

Effects of health savings account-eligible plans on utilization and expenditures. 2011

Outcome measurement in economic evaluations of public health interventions: a role for the capability approach? 2010

International comparison of comparative effectiveness research in five jurisdictions: insights for the US. 2010

Converting to critical access status: how does it affect rural hospitals’ financial performance? 2009

Factors associated with Iowa rural hospitals’ decision to convert to critical access hospital status. 2008

The economics of specialty hospitals. 2008

Effects of specialty hospitals on the financial performance of general hospitals, 1997-2004. 2007

Effect of critical access hospital conversion on patient safety. 2007

Clinical practice guidelines and organizational adaptation: a framework for analyzing economic effects. 2006

Implementation of hospital computerized physician order entry systems in a rural state: feasibility and financial impact. 2005

What would be the effect of referral to high-volume hospitals in a largely rural state? 2004